Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres

Journal of Controlled Release

Volumn 56, Issue 1-3, 1998, Pages 63-73

  Igartua, M ^a   Hernandez R M ^a   Esquisabel, A ^a   Gascon A R ^a   Calvo, M B ^a   Pedraz, J L ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Bovine serum albumin; Freund's complete adjuvant; Immune response; Microsphere; Poly(D,L lactide co glycolide); Vaccine

Indexed keywords

BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN; MICROSPHERE; POLYGLACTIN; RESOMER RG 503; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MANUFACTURE; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MODEL; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; BIOCOMPATIBLE MATERIALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FREUND'S ADJUVANT; IMMUNIZATION; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; LACTIC ACID; MICE; MICE, INBRED BALB C; MICROSPHERES; POLYGLYCOLIC ACID; POLYMERS; SERUM ALBUMIN, BOVINE;

EID: 0032484142     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(98)00077-7     Document Type: Article

References (27)

1. S.J. Cryz, Vaccines and Immunotherapy, McGraw-Hill, New York, 1991.
2. Freund J. The mode of action of immunologic adjuvants. Adv. Tuberc. Res. 7:1956;130-148.
3. Khan M.Z.L., Opdebeeck J.P., Tucker I.G. Immunopotentiation and delivery systems for antigens for single-step immunization, recent trends and progress. Pharm. Res. 11:1994;2-11.
4. Singh M., Singh O., Singh A., Talwar G.P. Immunogenicity studies on diphtheria toxoid loaded biodegradable microspheres. Int. J. Pharm. 85:1992;5-8.
5. Jenkins P.G., Coombes A.G.A., Yeh M.K., Thomas N.W., Davis S.S. Aspects of the design and delivery of microparticles for vaccine applications. J. Drug. Target. 3:1985;79-81.
6. Eyles J.E., Alpar H.O., Sharp G.J.E., Williamson E.D. Studies on the optimisation of microsphere formulation for Yersinia pestis antigens for oral delivery: humoral and cellular responses. Proc. Int. Symp. Control. Rel. Bioact. Mater. 24:1997;251-252.
7. Williams D.F. Biodegradation of surgical polymers. J. Mater. Sci. 17:1988;1233-1246.
8. D.T. O'Hagan, Novel Delivery Systems for Oral Vaccines, CRC Press, Boca Raton, 1994.
9. T. Kissel, R. Koneberg, Injectable biodegradable microspheres for vaccine delivery, in: S. Cohen, H. Bernstein (Eds.), Microparticulate Systems for the Delivery of Proteins and Vaccines, Marcel Dekker, New York, 1996, pp. 51-89.
10. R.W. Ellis, Vaccines. New Approaches to Immunological Problems, Butterworth-Heineman, Boston, 1992.
11. Igartua M., Hernández R.M., Esquisabel A., Gascón A.R., Calvo B., Pedraz J.L. Optimización del tamaño de partícula de microesferas de PLGA con albúmina bovina. Inf. Tec. 14:1997;627-638.
12. C. Washington, Particle Size Analysis in Pharmaceutics and other Industries. Theory and Practice, Ellis Horwood, Chichester, 1992.
13. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
14. Igartua M., Hernández R.M., Esquisabel A., Gascón A.R., Calvo B., Pedraz J.L. Influence of formulation variables on the in vitro release of albumin from biodegradable microparticulate systems. J. Microencaps. 14:1997;349-356.
15. Smith P.K., Kronh R.I., Hermanson G.T.et al. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
16. D.W. Chan, M.T. Perlstein, Immunoassay. A Practical Guide, Academic Press, San Diego, 1987.
17. O'Hagan D.T., Jeffery H., Davis S.S. The preparation and characterization of poly(lactide-co-glycolide) microparticles: III. Microparticle/polymer degradation rates and the in vitro release of a model protein. Int. J. Pharm. 103:1994;37-45.
18. Sah H., Toddywala R., Chien Y.W. The influence of biodegradable microcapsule formulations on the controlled release of a protein. J. Control. Release. 30:1994;201-211.
19. M. Igartua, R.M. Hernández, A. Esquisabel, A.R. Gascón, M.B. Calvo, J.L. Pedraz, Stability of BSA encapsulated into PLGA microspheres using PAGE and capillary electrophoresis, Int. J. Pharm. (1997) (In press).
20. E.P. Diamandis, T.K. Christopoulos, Immunoassays, Academic Press, San Diego, 1996.
21. Uchida T., Martin S., Foster T.P., Wardley R.C., Grimm S. Dose and load studies for subcutaneous and oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin. Pharm. Res. 11:1994;1009-1015.
22. E. Harlow, D. Lane, Antibodies. A Laboratory Manual, Cold Spring Harbor Laboratory, New York, 1988.
23. Hu J.G., Ide A., Yokoyama T., Kitagawa T. Studies on the optimal immunization schedule of the mouse as an experimental animal. The effect of antigen dose and adjuvant type. Chem. Pharm. Bull. 37:1989;3042-3046.
24. O'Hagan D.T., Jeffery H., Davis S.S. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. Vaccine. 11:1993;965-969.
25. Shahin R., Leef M., Eldridge J., Hudson M., Gilley R. Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(D,L-lactide-co-glycolide) microspheres. Infect. Immun. 4:1995;1195-1200.
26. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Control. Release. 11:1990;205-214.
27. O'Hagan D.T. Intestinal translocation of particulates implications for drug delivery. Adv. Drug. Del. Rev. 5:1990;265-285.